Company profile
Abacus Bioscience company profile
Abacus Bioscience specializes in developing immunotherapies for treating chronic infectious diseases and cancers. It provides a broad-based platform that can plug and play with multiple cancer or viral antigens. The company was founded in 2017 and is headquartered in Seattle, Washington.
Business identity
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Revenue range
- $1K+
- Founded
- 2017-01-01
Headquarters
- Headquarters
- Seattle, United States, Washington
- Country code
- US
- Continent
- North America